163 related articles for article (PubMed ID: 25659761)
1. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis.
Voigtländer T; Leuchs E; Vonberg RP; Solbach P; Manns MP; Suerbaum S; Lankisch TO
J Infect; 2015 May; 70(5):483-90. PubMed ID: 25659761
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation.
Kirchner GI; Scherer MN; Obed A; Ruemmele P; Wiest R; Froh M; Loss M; Schlitt HJ; Schölmerich J; Gelbmann CM
Scand J Gastroenterol; 2011 Apr; 46(4):471-8. PubMed ID: 21114429
[TBL] [Abstract][Full Text] [Related]
3. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
4. Biliary candida infections in primary sclerosing cholangitis.
Kulaksiz H; Rudolph G; Kloeters-Plachky P; Sauer P; Geiss H; Stiehl A
J Hepatol; 2006 Nov; 45(5):711-6. PubMed ID: 16979779
[TBL] [Abstract][Full Text] [Related]
5. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
6. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
[TBL] [Abstract][Full Text] [Related]
7. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome.
Voigtländer T; Negm AA; Schneider AS; Strassburg CP; Manns MP; Wedemeyer J; Lankisch TO
Endoscopy; 2012 Nov; 44(11):1055-8. PubMed ID: 23108773
[TBL] [Abstract][Full Text] [Related]
8. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.
Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Hetzer R; Schaffartzik W; Tryba M; Neuhaus P; Seehofer D
Crit Care; 2015 Mar; 19(1):131. PubMed ID: 25886728
[TBL] [Abstract][Full Text] [Related]
9. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.
Rupp C; Friedrich K; Folseraas T; Wannhoff A; Bode KA; Weiss KH; Schirmacher P; Sauer P; Stremmel W; Gotthardt DN
Aliment Pharmacol Ther; 2014 Apr; 39(8):873-82. PubMed ID: 24612312
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications.
Voigtländer T; Jaeckel E; Lehner F; Manns MP; Lankisch TO
Liver Transpl; 2015 Oct; 21(10):1295-9. PubMed ID: 26069199
[TBL] [Abstract][Full Text] [Related]
11. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis.
Rudolph G; Gotthardt D; Klöters-Plachky P; Kulaksiz H; Rost D; Stiehl A
J Hepatol; 2009 Jul; 51(1):149-55. PubMed ID: 19410324
[TBL] [Abstract][Full Text] [Related]
12. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
[TBL] [Abstract][Full Text] [Related]
13. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial.
Stahl K; Klein F; Voigtländer T; Großhennig A; Book T; Müller T; Wree A; Kuellmer A; Weigt J; Dechene A; Wedi E; Kandulski A; Lange CM; Holzwart D; von Witzendorff D; Ringe KI; Wedemeyer H; Heidrich B;
Trials; 2023 Mar; 24(1):247. PubMed ID: 37004078
[TBL] [Abstract][Full Text] [Related]
14. Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study.
Blesl A; Jüngst C; Lammert F; Fauler G; Rainer F; Leber B; Feldbacher N; Stromberger S; Wildburger R; Spindelböck W; Fickert P; Horvath A; Stadlbauer V
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32906634
[TBL] [Abstract][Full Text] [Related]
15. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis--a study of bile cultures from ERCP.
Björnsson ES; Kilander AF; Olsson RG
Hepatogastroenterology; 2000; 47(36):1504-8. PubMed ID: 11148988
[TBL] [Abstract][Full Text] [Related]
16. Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.
Gauss A; Ehehalt R; Lehmann WD; Erben G; Weiss KH; Schaefer Y; Kloeters-Plachky P; Stiehl A; Stremmel W; Sauer P; Gotthardt DN
World J Gastroenterol; 2013 Sep; 19(33):5454-63. PubMed ID: 24023488
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients.
Leonhardt S; Jürgensen C; Frohme J; Grajecki D; Adler A; Sigal M; Leonhardt J; Voll JM; Kruse JM; Körner R; Eckardt KU; Janssen HJ; Gebhardt V; Schmittner MD; ; Frey C; Müller-Ide H; Bauer M; Thibeault C; Kurth F; Sander LE; Müller T; Tacke F
Hepatol Int; 2023 Dec; 17(6):1610-1625. PubMed ID: 37119516
[TBL] [Abstract][Full Text] [Related]
18. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis.
Pohl J; Ring A; Stremmel W; Stiehl A
Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):69-74. PubMed ID: 16357622
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the bile microbiome in primary sclerosing cholangitis.
Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C
Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055
[TBL] [Abstract][Full Text] [Related]
20. Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
Pereira P; Aho V; Arola J; Boyd S; Jokelainen K; Paulin L; Auvinen P; Färkkilä M
PLoS One; 2017; 12(8):e0182924. PubMed ID: 28796833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
